Valo Health, Inc. products

Our Biowire II platform applies biomimetic stimulation to produce engineered cardiac tissue with unprecedented adult-like human physiology. Our tissues overcome the limitations of current technology by more accurately & more quickly predicting the efficacy & safety of new medicines in early development.

Opal is the first end-to-end integrated drug discovery & development platform. Traditional, linear approaches to target discovery and drug development have created sub-optimized systems that are intrinsically disintegrated and disconnected.